Advertisement

Topics

Latest "Scios Incorporated" News Stories

10:51 EST 15th December 2017 | BioPortfolio

Here are the most relevant search results for "Scios Incorporated" found in our extensive news archives from over 250 global news sources.

More Information about Scios Incorporated on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Scios Incorporated for you to read. Along with our medical data and news we also list Scios Incorporated Clinical Trials, which are updated daily. BioPortfolio also has a large database of Scios Incorporated Companies for you to search.

Showing "Scios Incorporated" News Articles 1–25 of 40

Relevant

Vical Incorporated Announces Pricing of $25 Million Underwritten Public Offering of Common Stock

SAN DIEGO, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced the pricing of its underwritten public offering of 14,285,714 shares of common stock or common stock equivalents at a price to the public of $1.75 per share.  H.C. Wainwright & Co., LLC is acting as the sole book-running manager for the offering. The gross proceeds from this offering are exp...


Probably Relevant

Quidel Confident in Legal Strength and Validity of Supply Agreement with Beckman Coulter to Sell BNP Assay Assets

The company plans to vigorously defend its position Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, acknowledged Beckman Coulter (“Beckman”) plans to pursue commercial litigation to allow it to sell BNP directly to customers, contrar...

Milestone Scientific Announces Children's Hospital of Pittsburgh to use The Wand(R) Computer Assisted Anesthesia System for Pediatric Patients

LIVINGSTON, NJ --(Marketwired - September 14, 2017) - Milestone Scientific Inc. (NYSE American: MLSS) (NYSE MKT: MLSS), a medical company that develops and commercializes a growing portfolio of proprietary injection technologies, today announced that the Children's Hospital of Pittsburgh will now utilize The Wand® computer assisted anesthesia system for its pediatric patients. In addition, The Wa...


Possibly Relevant

Novartis tender offer for Advanced Accelerator Applications commences

Novartis International AG / Novartis tender offer for Advanced Accelerator Applications commences . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement. Basel, December 7, 2017 -Novartis AG (NYSE: NVS) ("Novartis") today announced that its direct and indirect subsidiary, Novartis Groupe France S...

Pharmacovigilance Database E2B(R3) Compliance: A Technical and Practical Perspective

TORONTO, ON--(Marketwired - October 06, 2017) - In a complimentary webinar taking place on Thursday, October 26, 2016 at 11am EDT (4pm BST) industry experts Tom Nichols, Senior Director of Pharmacovigilance at Quanticate and Dr. Marc Zittartz, Chief Quality Officer at Pharmasol will address a major step forward in the pharmaceutical industry from both a technical perspective as well as the day-to...

Teleflex Incorporated Completes Acquisition of NeoTract

Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies designed to improve the health and quality of people’s lives, announced today the completion of its previously announced acquisition of NeoTract, Inc. On September 5, 2017, the two companies announced a definitive agreement for Teleflex to acquire NeoTract in a ...

MetLife Hong Kong Expands Coverage for People with Diabetes and Introduces Insurtech Solution

HONG KONG, CHINA -- (Marketwired) -- 09/19/17 -- MetLife Hong Kong* announced today that it has extended the scope of its "MetLife Health-is-Wealth Medical Plan" to include people living with diabetes, and offered its customers insurtech solutions for proactive health management. For the 1 in 10 people in Hong Kong living with diabetes, finding insurance cover that provides comprehensive coverage...

Hydropothecary releases versatile Decarb Micro THC and Decarb Micro CBD medical marijuana powders at $3 per gram

GATINEAU, QC--(Marketwired - November 03, 2017) - The Hydropothecary Corporation ("Hydropothecary" or the "Company") (TSX VENTURE: THCX) is pleased to announce the release of two new products, Decarb Micro THC and Decarb Micro CBD. Part of the Company's unique innovative line of Decarb products, Decarb Micro THC and Decarb Micro CBD are ready-to-consume, activated medical marijuana powders. Deca...

Amedica Announces Adjournment of Special Meeting of Stockholders

SALT LAKE CITY, UT -- (Marketwired) -- 08/14/17 -- Amedica Corporation (NASDAQ: AMDA), an innovative medical device company that develops and commercializes silicon nitride, announced that the special meeting of stockholders scheduled for today has been adjourned, with the adjournment itself being the only business conducted. The adjournment is to allow for the solicitation of additional votes i...

Study Confirms RenalGuard(R) Efficacy for Dramatically Lowering Risk of Contrast-Induced Acute Kidney Injury

MILFORD, MA--(Marketwired - August 29, 2017) - New clinical research confirms the ability of RenalGuard® to dramatically lower the risk of contrast-induced nephropathy (CIN) compared to the risk predicted by validated Mehran CIN scores for patients with kidney impairment who are exposed to contrast agents as part of cardiac catheterization procedures. Moreover, 58 patients undergoing such procedu...

Tauriga Sciences, Inc. and Ice + Jam LLC Prepare for Autumn 2017 Commercial Product Launch with Commencement of Laboratory Work to Reformulate Cupuacu Butter Lip Balm Product Texture

NEW YORK, NY -- (Marketwired) -- 07/25/17 -- Tauriga Sciences, Inc. (OTC PINK: TAUG) ("Tauriga" or the "Company"), engaged in the building of life sciences businesses and technologies, today announced that, in cooperation with its licensor Ice + Jam LLC ("Ice + Jam"), it is working with New Jersey based Cosmetics R & D Laboratory, Ariel Laboratories ("Ariel Labs"), to reformulate its propriet...

FIT Biotech Oy: Resolutions of Extraordinary General Meeting December 14, 2017

FIT Biotech OyCompany release December 14, 2017 at 12 am. Resolutions of Extraordinary General Meeting December 14, 2017                The EGM of FIT Biotech ("FIT Biotech", "company") has made the following resolutions today. Amendment to the Articles of Association    The Extraordinary General Meeting resolved to amend section 4 of ...

Molecular Health and U.S. Food and Drug Administration (FDA) Extend Software Collaboration to Drug Safety Prediction

Molecular Health GmbH / Molecular Health and U.S. Food and Drug Administration (FDA) Extend Software Collaboration to Drug Safety Prediction . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement. Cambridge, MA, USA - November 16, 2017 -  Molecular Health, Inc (MH), a company marketing computational biomedicine...

Teleflex Incorporated Announces Public Offering of $500 Million of Senior Notes

Teleflex Incorporated (NYSE: TFX) (“Teleflex”) announced today the registered public offering, subject to market and other conditions, of $500.0 million aggregate principal amount of senior notes due 2027 (the “Notes”). The interest rate and other terms of the Notes will be determined at pricing. The Notes will be guaranteed by each of Tel...

Teleflex Incorporated Announces Pricing of $500 Million Senior Notes Offering

Teleflex Incorporated (NYSE: TFX) (“Teleflex”) announced today that it priced its offering of $500.0 million aggregate principal amount of 4.625% senior notes due 2027 (the “Notes”) at an issue price of 100.000%. The sale of the Notes is expected to close on November 20, 2017, subject to customary closing conditions. The Notes will be guar...

Dynavax Initiates Clinical Trial in Non-Small Cell Lung Cancer with a Novel Inhaled TLR9 Agonist in Combination with Anti-PD-1 Therapy

BERKELEY, CA--(Marketwired - October 19, 2017) - Dynavax Technologies Corporation (NASDAQ: DVAX) announced initiation of dosing in a phase 1B dose escalation clinical trial of its investigational inhaled toll-like receptor 9 (TLR9) agonist, DV281, in patients with non-small cell lung cancer (NSCLC). This multi-center, open label trial is designed to evaluate safety and identify the optimal dose f...

Microbix Announces Expanded Customer Supply Agreement

TORONTO, ONTARIO -- (Marketwired) -- 08/08/17 -- Microbix Biosystems Inc. (TSX: MBX), an innovator of biological products and technologies, announces the execution of an agreement to supply an existing long-term customer with an increasing quantity of Microbix' viral antigen products over the next five years, with the parties having the option to extend that term. Sales from the agreement are ex...

Mincom Provides Update on Proposed Transaction

OTTAWA, ONTARIO -- (Marketwired) -- 08/01/17 -- Mincom Capital Corporation ("Mincom" or the "Corporation") (TSX VENTURE: MOI) is pleased to provide the following update with respect to a transaction to purchase all of issued and outstanding shares of Braille Holdings Inc. held by Grafoid Inc. (the "Proposed Transaction"). The Proposed Transaction was previously announced on October 18, 2016 and ...

Advanced Bifurcation Systems Announces Plan for Human Clinical Trials in New Brunswick, Canada

LOS ANGELES, Oct. 03, 2017 (GLOBE NEWSWIRE) -- Advanced Bifurcation Systems ("ABS" or the "Company"), a clinical stage medical device company developing an innovative stenting platform which overcomes the limitations of current approaches for the treatment of bifurcation lesions in coronary angioplasties, today announced that the Company is planning to undertake human cl...

Milestone Scientific's CompuFlo(R) Epidural System, Wand(R) STA Dental System and Cosmetic Instrument Featured in Television Broadcasts and in Premier Online News Journal

LIVINGSTON, NJ--(Marketwired - November 28, 2017) - Milestone Scientific Inc. (NYSE American: MLSS) (NYSE MKT: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that its Wand® STA Dental and CompuFlo® Epidural systems were featured in separate television news broadcasts in Pittsburgh and South Florida, respectively....

Resverlogix Closes Previously Announced $87 Million Private Placement with Shenzhen Hepalink

CALGARY, Alberta, Dec. 04, 2017 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) announced today that it has closed its previously announced private placement of 60,416,667 equity units to Shenzhen Hepalink Pharmaceutical Co. Ltd. ("Hepalink") at a price of $1.44 per unit for gross proceeds of $87 million. Each unit was comprised ...

Cheese Market by Source Cow Milk, Sheep Milk, Goat Milk, and Buffalo Milk, Type Natural Cheese and Processed Cheese, Product Mozzarella, Cheddar, Feta, Parmesan, Roquefort, and Others, and Distribution Channel Hypermarkets, Supermarkets, Food Specialty St

Cheese is one of the most consumed food products, owing to its high nutritious value along with presence of necessary vitamins, proteins, and other nutrients. It is a rich source of calcium that helps to maintain strong teeth and increases bone strength. Further, cheese contains linoleic acid and sphingolipids, which helps to prevent cancer. Moreover, vitamin B present in cheese can reduce blood p...

Mannatech Reports Second Quarter 2017 Financial Results

Mannatech, Incorporated (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, today announced financial results for its second quarter of 2017. Second Quarter Results Second quarter net

Teleflex Reports Second Quarter 2017 Results

Second Quarter Revenues of $528.6 million, up 11.6% Versus Prior Year Period; up 12.9% on Constant Currency Basis Second Quarter GAAP Diluted EPS of $1.67, up 33.6% Over Prior Year Period Second Quarter Adjusted Diluted EPS of $2.04, up 7.9% Versus Prior Year Period Raised 2017 Guidance Range for GAAP Revenue Growth from a...

Mannatech Reports Third Quarter 2017 Financial Results

Mannatech, Incorporated (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, today announced financial results for its third quarter of 2017. Third Quarter Results Third quarter net


Quick Search
Advertisement
 

News Quicklinks